Vontobel Holding
BCYC icon

Vontobel Holding’s Bicycle Therapeutics BCYC Stock Holding History

Vontobel Holding’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84.6K Buy
23,000
+3,000
+15% +$12.1K ﹤0.01% 1435
2026
Q2 		$84.8K Hold
20,000
– – ﹤0.01% 1421
2026
Q1 		$92.8K Buy
20,000
+10,000
+100% +$57.1K ﹤0.01% 1153
2025
Q4 		$70.8K Buy
+10,000
New +$73.7K ﹤0.01% 1385

Other funds holding BCYC

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Woodstock Corp
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.71B AUM 23.29% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.2B AUM 30.02% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Vontobel Holding's BCYC Position: Q3 2026 in Review

Vontobel Holding increased its Bicycle Therapeutics (BCYC) stake by 15% in Q3 2026, buying an estimated $12.1K and bringing the position to 23,000 shares worth $84.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

Vontobel Holding first reported a position in BCYC in Q4 2025 and has held it in 4 quarters since. The position peaked at $92.8K in Q1 2026. 25 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Vontobel Holding held 23,000 shares of Bicycle Therapeutics worth $84.6K as of Q3 2026.
  • Vontobel Holding bought 3,000 Bicycle Therapeutics shares in Q3 2026, an estimated $12.1K.
  • Bicycle Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1435 holding.
  • Vontobel Holding first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Vontobel Holding's Bicycle Therapeutics position peaked at $92.8K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.